UK markets closed

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
34.54+0.39 (+1.14%)
As of 01:57PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
93,294
48,155
-25,002
71,517
26,752
Depreciation & amortisation
146,407
149,256
138,939
68,917
61,550
Deferred income taxes
-6,519
-2,153
-8,391
-78,042
0
Stock-based compensation
28,576
27,136
22,874
24,255
21,910
Change in working capital
40,976
21,731
-12,713
13,486
-25,299
Accounts receivable
4,433
3,594
-21,780
-22,524
-10,367
Inventory
1,619
14,169
48,274
-2,296
-8,270
Accounts payable
3,027
5,061
-707
-5,827
3,769
Other working capital
308,162
274,288
122,608
101,613
-279,830
Other non-cash items
7,931
8,355
8,523
3,424
9,029
Net cash provided by operating activities
309,015
274,749
124,230
103,557
93,942
Cash flows from investing activities
Investments in property, plant and equipment
-853
-461
-1,622
-1,944
-373,772
Acquisitions, net
-
0
-572,069
0
-
Purchases of investments
-131,461
-92,351
0
0
-
Sales/maturities of investments
43,550
22,000
0
0
-
Net cash used for investing activities
-88,764
-70,812
-573,691
-1,944
-373,772
Cash flows from financing activities
Debt repayment
-183,333
-301,138
-75,000
-50,000
-49,000
Common stock issued
-
-
-
-
0
Common stock repurchased
-
-75,000
-14,063
-47,861
0
Other financing activities
-13,499
-8,361
-4,044
-4,149
-2,255
Net cash used provided by (used for) financing activities
-262,621
-140,178
436,723
-89,303
286,474
Net change in cash
-42,370
63,759
-12,738
12,310
6,644
Cash at beginning of period
272,027
176,235
188,973
176,663
170,019
Cash at end of period
229,657
239,994
176,235
188,973
176,663
Free cash flow
Operating cash flow
309,015
274,749
124,230
103,557
93,942
Capital expenditure
-853
-461
-1,622
-1,944
-373,772
Free cash flow
308,162
274,288
122,608
101,613
-279,830